Project Number 2P50AG005136-32 Agency/Funding Organization NIA Funding Year 2015 View Full Project Details for MECHANISMS LINKING NORMATIVE AGING WITH ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 1. Amyloid beta g. Amyloid beta-Mediated Pathogenesis Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator KAEBERLEIN, MATT Principal Investigator First Name MATT Principal Investigator Last Name KAEBERLEIN Awardee Organization UNIVERSITY OF WASHINGTON Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-15-002: Alzheimer's Disease Research Centers (P50) FY Overall Cost $193,125 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [AlzPED] Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model Clinical Trial Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days Alzheimer's in Long-Term Care--Treatment for Agitation Pagination Previous page ‹‹ Page 2
